American Journal of Psychiatry Audio

Dr. Charles Conway (Washington University School of Medicine, St. Louis) joins the podcast to discuss the RECOVER trial, a RCT that looked at vagus nerve stimulation and its effects on profoundly treatment resistant depression. Following that, AJP Editor-in-Chief Dr. Ned Kalin is joined by the October issue guest editor, Dr. William McDonald (Emory University, Atlanta) to discuss the rest of the October issue, which focuses on neuromodulation and precision therapeutics.

• 00:42 Conway interview
• 02:34 Quality of life
• 05:13 Ethical considerations of a sham arm in this population
• 07:00 Timing and VNS treatment
• 08:03 Clinical implications
• 09:02 Limitations
• 10:12 Further research
• 11:30 McDonald and Kalin interview
• 13:50 Song et al.
• 14:08 Li et al.
• 15:44 Donnery et al.
• 16:38 Valiengo et al.
• 17:28 Rush
• 20:03 Mahmoudi
• 22:37 Conway et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

Dr. Heon-Jeong Lee (Korea University, Seoul) joins AJP Audio to discuss an app-based intervention designed to help individuals with mood disorders regulate their circadian rhythms to prevent recurrence of mood episodes. Afterwards, Dr. Ned Kalin will join us again to discuss the rest of the September issue of the Journal, which takes a close look at clinical treatment.

• 00:44 Findings
• 01:42 How the app works
• 03:05 Differences between the app and traditional lifestyle advice
• 04:14 Ethics surrounding shame treatment arms
• 05:43 Broader applicability of the intervention
• 06:50 Limitations
• 08:19 Immediate clinical implications
• 09:33 Further research
• 10:08 Kalin interview
• 10:27 Yeom et al.
• 16:02 Schacht et al.
• 20:31 Khosravani et al.
• 24:52 Peterson et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

Amandeep Jutla, M.D., joins Dr. Dixon and Dr. Berezin, with guest host Dr. Matt Hirschtritt, to discuss concerns surrounding the use of large language model chatbots and psychiatric risk.

• 01:08 Introduction
• 04:03 Language models in 2019
• 05:18 The appeal of chat-based AI for autistic adults
• 07:34 Do you use chat-based AI models personally?
• 09:44 Specific concerns of interacting with AI chat bots
• 11:07 The illusion of speaking with a person
• 13:34 Suggestions for clinicians and researchers
• 16:17 Questions a clinician should ask
• 18:29 Uses for AI models
• 20:11 Can chat bots get good at providing advice?
• 21:30 Regulations?
• 24:12 Motivational interviewing

Transcript

Subscribe to the podcast here.

Check out Editor's Choice, a set of curated collections from the rich resource of articles published in the journal. Sign up to receive notification of new Editor's Choice collections.

Browse other articles on our website.

Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it.

Listen to other podcasts produced by the American Psychiatric Association.

Follow the journal on Twitter. E-mail us at [email protected]

Dr. Deepak Cyril D'Souza (Yale University School of Medicine) joins the podcast to discuss a study looking at two cohorts of patients hospitalized with first instances of psychosis, one with cannabis exposure and one without. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the August issue of the Journal, which takes a look at issues surrounding schizophrenia spectrum disorder, from the clinical to basic science.

• 00:40 D'Souza interview
• 02:38 Subtyping and schizophrenia spectrum disorder
• 04:19 Relapse and long-term implications for cannabis induced psychosis
• 05:43 Improvements in cognition
• 08:03 Differences between the groups
• 09:26 Greater access and greater potency of cannabis products
• 11:29 Further research
• 13:45 Kalin interview
• 13:59 D'Souza et al.
• 21:34 Forsyth et al.
• 27:36 Enwright et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

Dr. Dilip Jeste (Social Determinants of Health Network, La Jolla, CA) joins the podcast to discuss how social determinants of health interact with treatment for psychiatric disorders. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin once again puts the rest of the July issue into context.

• 00:31 Impacts of social determinants of health on psychiatric disorders, research, and clinical care
• 04:43 Health related social needs versus social determinants of health
• 08:47 Loneliness as a risk factor
• 12:36 A clinician's role in societal factors
• 14:47 Mechanistic understandings social determinants and the exposome
• 18:17 Further research
• 22:25 Kalin interview
• 22:30 Jeste and Gyan
• 23:33 Blundell et al.
• 28:03 Yang et al.
• 32:20 Van der Meer et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

Dr. Jason Tucciarone and Dr. Alan Schatzberg (Stanford University, Stanford, CA) join AJP Audio to discuss the use of low-dose buprenorphine as an adjunctive therapy to extend the anti-suicidal effects of ketamine treatment in patients with major depressive disorder and suicidal ideation. AJP Editor-in-Chief Dr. Ned Kalin joins to discuss the rest of the June issue of the Journal, which takes a close look at issues surrounding suicide and severe depression.

• 01:20 Tucciarone and Schatzberg interview
• 03:36 Disparity between effects on suicidal ideation and antidepressant ratings
• 05:36 Ethics of placebo and ketamine in patients with suicidal ideation
• 08:28 Immediate clinical implications
• 11:40 Limitations
• 14:10 Further research
• 16:19 Kalin interview
• 16:24 Tucciarone et al.
• 20:39 Rovers et al.
• 24:30 Jelen et al.

Transcript

Board-certified psychiatrists, if you're seeking meaningful inpatient work with real clinical autonomy, consider becoming the Clinical Director for a 16-bed behavioral health hospital in Fergus Falls or Bemidji, Minnesota. You'll lead a supportive interdisciplinary team, enjoy predictable work-life balance, and have opportunities for teaching and mentorship without RVU pressure or third-party billing. Learn more on APA's Career Center, JobCentral, by searching Direct Care and Treatment – State of Minnesota.

Direct Care and Treatment – State of Minnesota: bit.ly/DCTClinicalDirector

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

In this special episode of AJP Audio, AJP Editor-in-Chief Dr. Ned Kalin is joined by Dr. María Oquendo (Perelman School of Medicine at the University of Pennsylvania, Philadelphia), chair of APA's Future DSM Strategic Committee to discuss a series of commentaries published in the May issue of the Journal discussing the strategic vision for the future of DSM.

• 00:39 Oquendo interview
• 03:07 Size of the response
• 04:18 Feedback
• 06:04 Incorporating the feedback
• 07:57 Emphasizing science with a title change for DSM
• 10:18 A living document
• 12:35 Changes from previous versions of DSM
• 16:08 Changes in documentation and coding
• 18:51 Lived experience
• 20:02 Working with AJP

Links to the commentaries:

• Initial Strategy for the Future of DSMMaría A. Oquendo, M.D., Ph.D., et al.
• The Future of DSM: A Report From the Structure and Dimensions SubcommitteeDost Öngür, M.D., Ph.D., et al.
• The Future of DSM: Are Functioning and Quality of Life Essential Elements of a Complete Psychiatric Diagnosis?Karen Drexler, M.D., et al.
• The Future of DSM: Role of Candidate Biomarkers and Biological FactorsBruce Cuthbert, Ph.D., et al.
• The Future of DSM: A Strategic Vision for Incorporating Socioeconomic, Cultural, and Environmental Determinants and IntersectionalityMilton L. Wainberg, M.D., et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

Dr. Eduardo Butelman (Icahn School of Medicine at Mount Sinai, New York) joins AJP Audio to discuss the varying incidence of psychiatric comorbidities across patients diagnosed with substance use disorders. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to discuss the rest of the May issue, which includes a discussion on the future of the DSM.

• 00:53 Butelman interview
• 02:23 Mechanisms of difference between males and females
• 04:04 Patterns of response between males and females in substance use disorders
• 05:54 Implications for research into sex-based differences
• 07:33 Racial and ethnic variations in findings
• 09:30 Limitations
• 10:46 Immediate clinical implications?
• 12:09 Further research
• 13:18 Kalin interview
• 13:38 Butelman et al.
• 17:11 Hinojosa et al.
• 22:49 van Rooij et al.
• 26:06 The future of DSM

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

Yang Lu, M.S., and Catharine E. Fairbairn, Ph.D. (University of Illinois, Urbana-Champaign) join AJP Audio to discuss the longitudinal effects of the use of personal alcohol breathalyzers in a natural setting on alcohol usage. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to discuss the rest of the April issue, which focuses on subjects related to substance use disorders.

• 00:57 What did you discover about the long term effects of using a personal blood alcohol monitor?
• 03:12 Do health monitoring devices actually change behaviors?
• 04:10 What did your cohort look like?
• 08:49 Disparate impact of monitoring on heavy drinkers and light drinkers
• 11:36 Clinical implications
• 14:34 Limitations
• 15:46 Avenues for further research
• 18:39 Kalin interview
• 18:46 Lu et al.
• 24:00 Wittekind et al.
• 29:50 Nicholson et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]

Chelsea Dyan Gober Dykan, M.A. (Tel Aviv University, Israel), joins AJP Audio to discuss a study looking at two versions of attention bias modification with an eye towards a prophylactic impact on developing PTSD in a cohort of combat-bound soldiers. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to put the rest of the March issue into context.

• 00:57 Attention bias modifications
• 03:54 Response-time and gaze-contingent paradigms
• 05:05 Differences in efficacy between the two arms
• 08:06 Ethical considerations in investigating combat-bound soldiers
• 10:44 Controlling for combat experiences in studying PTSD
• 12:24 Duration of the effect
• 13:44 Limitations
• 15:03 Immediate clinical implications
• 16:22 Further research
• 17:05 Kalin interview
• 17:22 Dykan et al.
• 21:03 Kaul et al.
• 26:19 Kantrowitz et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at [email protected]